Milestones
- Percept PC approved by FDA25 Jun 2020Complete.
- FDA approval for Parkinson's with BrainSense adaptive DBS8 Jan 2024Complete.
- First Percept RC implants in US performedJan 2024Complete.

by MedtronicIE
Rechargeable DBS system with BrainSense sensing. Automatically adjusts stimulation based on brain signals.
FDA approved Jan 2024. First adaptive (closed-loop) DBS for Parkinson's with BrainSense sensing.
Updated 8 Jan 2024Checked 10 Oct0 updates this week
Electrodes capture signals correlated with symptoms; analyzed in real time.
When brain activity indicates worsening symptoms, device increases stimulation.
Matches stimulation to each patient's unique neural signature, reducing side effects.
Home recharging like hearing aids avoids replacement surgeries.
| Spec | Percept RC |
|---|---|
| Size | Smallest dual-channel rechargeable DBSR (reported) |
| Technology | BrainSense closed-loop sensing and adaptiveR (reported) |
| FDA approvals | Parkinson's, tremor, dystonia, OCD, epilepsyR (reported) |
| Charging | Rechargeable, eliminates replacement surgeryR (reported) |
R reported by the company
Medtronic
Medical devices, DBS, neuromodulation, surgery robots
Global medical technology company developing deep brain stimulation, neuromodulation, and surgical robots. Medtronic leads in adaptive DBS with Percept RC and in surgical robotics with Hugo RAS.